As our label-free technologies perform drug-target MoA under physiological environments and in human samples, the test compound preserves its original structure as well as the exact same molecular structure that would be used in therapy.

We provide unbiased information about your drug and its natural environment that helps you find:
  • The extreme limits of the physiological process
  • How the physiological process can be modulated
  • Why the individual is responding to this compound at the molecular level
  • A description of the pathophysiology of the disease
  • The differences between the pathology and physiology


Identify the mode of action of your compound

From preclinical to clinical

Adopt a robust solution that can ensure the success of your Phase II study and accompany you in achieving the success of your drug candidate in Phase III


Identify a cohort of patients responding to your therapy